IL17A and cancer: Next, the IRS scale variables—the percentage of IL-17A-positive cancer cells (“A” score in the IRS scale) and the intensity of staining IL-17A-positive cancer cells (“B” score in the IRS scale) in the prostate and LN+—were independently examined to further the analysis of the pathological characteristics or postoperative results of the patients.